Controversies in off-label prescriptions in dermatology: the perspective of the patient, the physician, and the pharmaceutical companies

International Journal of Dermatology
Katlein França, Sergio Litewka

Abstract

The term "off-label drug use" involves the prescription of medications for unapproved indications or in unapproved dosage, dosage form, or route of administration. Off-label medications are common in the management of dermatologic diseases. In the recent years, new indications for botulinum toxin, biologics, spironolactone, topical calcineurin, and topical vitamin D analogues emerged, and these drugs are being used off-label to treat a variety of conditions. The high cost and long time required for the approval discourage pharmaceutical companies from developing studies and pursuing the approval by regulatory agencies. Patients and physicians may have a different perspective regarding the off-label use of medications. The ethical discussion is based on the different opinions concerning the need for informed consent by the patient and how this could be applicable in the clinical practice.

References

Apr 27, 2001·Expert Opinion on Investigational Drugs·S A Doggrell, L Brown
Jul 26, 2002·Journal of the American Academy of Dermatology·Joel H SugarmanSteven R Feldman
May 10, 2006·Archives of Internal Medicine·David C RadleyRandall S Stafford
Oct 24, 2007·Indian Journal of Ophthalmology·Bakulesh Khamar
Nov 16, 2007·International Journal of Impotence Research·W A Meadows, B D Hollowell
Apr 4, 2008·The New England Journal of Medicine·Randall S Stafford
Oct 31, 2008·PLoS Medicine·Adriane Fugh-Berman, Douglas Melnick
Aug 11, 2012·Mayo Clinic Proceedings·Christopher M WittichWilliam L Lanier
Oct 5, 2012·The New England Journal of Medicine·Joseph EmmerichAnnie Lorence
Oct 12, 2012·International Journal of Clinical Pharmacy·Marina RibeiroAna Filipa Macedo
Jan 29, 2013·The Virtual Mentor : VM·Zain Mithani
Apr 3, 2013·Ciência & saúde coletiva·Patricia Fernandes da Silva Nobre
Oct 24, 2013·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·C M SalavastruG S Tiplica
Mar 19, 2014·Journal of Cutaneous Medicine and Surgery·Heidi Wat, Marlene Dytoc
May 7, 2014·The American Journal of Gastroenterology·Arthur A CiociolaUNKNOWN FDA-Related Matters Committee of the American College of Gastroenterology
May 7, 2014·Journal of Pharmacology & Pharmacotherapeutics·Sandeep Kumar Gupta, Roopa Prasad Nayak
Dec 17, 2014·Pediatrics·Aurore PalmaroMaryse Lapeyre-Mestre
Oct 1, 2015·Acta Médica Portuguesa·Joana SilvaHercília Guimarães
Nov 5, 2015·Revista paulista de pediatria : orgão oficial da Sociedade de Pediatria de São Paulo·Marcele Giacomin Gonçalves, Isabela Heineck
Nov 22, 2015·Revista paulista de pediatria : orgão oficial da Sociedade de Pediatria de São Paulo·Marisa Lima Carvalho
Jul 17, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV·E ForbatF Al-Niaimi
Oct 30, 2016·Dermatologic Therapy·Katlein França, Torello Lotti
Mar 17, 2017·Wiener medizinische Wochenschrift·Katlein FrançaMaria Grazia Roccia
Apr 21, 2017·Dermatologic Therapy·Katlein FrançaTorello Lotti
May 26, 2017·American Journal of Clinical Dermatology·Maria Relvas, Tiago Torres
Jun 15, 2017·Skin Appendage Disorders·Anna CampanatiAnnamaria Offidani
Oct 25, 2017·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Karin Ellen Katharina SeidenschnurRicardo Niklas Werner

❮ Previous
Next ❯

Citations

Aug 15, 2019·British Journal of Clinical Pharmacology·Jan BorysowskiAndrzej Górski
May 27, 2020·Journal of Pharmaceutical Policy and Practice·Vesa HalimiAleksandra Grozdanova
Nov 11, 2020·Pediatric Dermatology·Megan E FreezeAlan B Fleischer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

© 2022 Meta ULC. All rights reserved